China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| HK |
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
10.3B HKD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
976.4B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
590.4B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
294.6B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
248.5B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
306.5B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.2B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.7B USD |
Loading...
|
Market Distribution
| Min | -239 513 300% |
| 30th Percentile | -12.9% |
| Median | 0.5% |
| 70th Percentile | 5.3% |
| Max | 203 056% |
Other Profitability Ratios
China Traditional Chinese Medicine Holdings Co Ltd
Glance View
China Traditional Chinese Medicine Holdings Co Ltd sits at the crossroads of ancient wisdom and modern commerce. Rooted deeply in the rich heritage of Traditional Chinese Medicine (TCM), this company skillfully crafts a range of products that cater to both domestic and international markets. At the core of its operations is the cultivation and processing of Chinese medicinal herbs, which are transformed into a wide portfolio of products, including ready-to-use TCM formula granules, patented medicines, and healthcare products. By leveraging its extensive network of cultivation bases, the company ensures the authenticity and quality of its raw materials, an essential component in a sector where the efficacy of products is deeply entwined with their origins. The company’s business model thrives on vertical integration, which allows it to exercise control over the entire supply chain—from the sourcing of raw materials to the manufacturing and distribution processes. Through this multifaceted approach, China Traditional Chinese Medicine Holdings Co Ltd maximizes its profit margins while maintaining stringent quality standards, crucial in a market where consumer trust is paramount. The firm's robust distribution network spans pharmacies, hospitals, and retail outlets, supplemented by a growing e-commerce presence. As healthcare trends increasingly lean towards natural and holistic remedies around the globe, the company finds itself well-positioned to not only cater to traditional markets but also to explore new opportunities in alternative medicine sectors worldwide.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for China Traditional Chinese Medicine Holdings Co Ltd is -1.7%, which is below its 3-year median of 3.3%.
Over the last 3 years, China Traditional Chinese Medicine Holdings Co Ltd’s Net Margin has decreased from 8.4% to -1.7%. During this period, it reached a low of -1.7% on Jun 30, 2025 and a high of 8.4% on Jun 30, 2022.